Vanguard Cancer Foundation
Financial Assistance

In 1994, we tested Jake D. Phillips, a lung cancer patient with advanced disease. We found a treatment that gave him added time and value to his life — a fact for which his sister, Loretta Stamos (mother of actor John Stamos), was forever thankful.

To show her appreciation and help others fighting cancer, Loretta created the Vanguard Cancer Foundation to support our work here. 

Click here to see Loretta with John Stamos explain this in a short 1 1/2 minute video segment on Extra TV.

Screen Shot 2021-01-22 at 2.51.11 PM.png

What They Do

Born from the dream of one dedicated physician and the love of a sister for her brother, Vanguard Cancer Foundation is a nonprofit entity with a mission to empower cancer patients through education, awareness, and financial assistance to make informed decisions about their best cancer drug treatment options.

The Vanguard Cancer Foundation provides for programs to educate patients and the public about personalized care for cancer treatment. It also funds endeavors that further the progress of specific research projects, which support, validate, and advance the assay-directed approach for selecting drugs and combinations for cancer patients.

How They Can Help

At Nagourney Cancer Institute, our goal is to avoid ever saying “no” to a financially disadvantaged patient.

Thanks to the support of Vanguard, we are almost always able to reach this goal. Vanguard Cancer Foundation grants financial aid strictly to individuals who are unable to afford the cost of our EVA-PCD functional profiling test.

Each patient’s application is reviewed and voted on by the Board of Directors. There is no discrimination based on age, gender, race or religion.

  • Facebook
  • YouTube
  • Instagram

Nagourney Cancer Insitute is managed by Rational Therapeutics, LLC.  EVA-PCD, Target Rx, and Translational Rx are registered trademarks of Rational Therapeutics.

2019 Nagourney Cancer Institute.  750 E. 29th Street, Long Beach, CA 90806   (800) 542-4357   All rights reserved.